Jazz Pharmaceuticals plc

JAZZ

$170.09

Name : Jazz Pharmaceuticals plc

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $10,335,538,176.00

EPSttm : -6.15

Jazz Pharmaceuticals plc

$170.09

20.57%

$29.02

Float Short %

8.85

Margin Of Safety %

-18

Put/Call OI Ratio

0.16

EPS Next Q Diff

-2.35

EPS Last/This Y

-0.89

EPS This/Next Y

14.52

Price

170.22

Target Price

194.25

Analyst Recom

1.2

Performance Q

42.69

Relative Volume

9.23

Beta

0.33

Ticker: JAZZ

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-10-20	JAZZ	134.78	0.14	0.19	12533
2025-10-21	JAZZ	137.47	0.14	0.30	12626
2025-10-22	JAZZ	138.55	0.14	0.08	12724
2025-10-23	JAZZ	138.2	0.14	0.28	12981
2025-10-24	JAZZ	138.52	0.14	0.06	13006
2025-10-27	JAZZ	139.28	0.14	0.06	13075
2025-10-28	JAZZ	138.12	0.14	0.61	13324
2025-10-29	JAZZ	135.68	0.14	0.04	13353
2025-10-30	JAZZ	136.27	0.14	0.17	13355
2025-10-31	JAZZ	137.6	0.14	0.56	13367
2025-11-03	JAZZ	138.37	0.15	0.03	13527
2025-11-04	JAZZ	137.85	0.15	0.16	13530
2025-11-05	JAZZ	137.37	0.15	2.47	13556
2025-11-06	JAZZ	134.07	0.16	0.06	13736
2025-11-07	JAZZ	131.21	0.16	0.04	13947
2025-11-10	JAZZ	133.24	0.15	0.36	15369
2025-11-11	JAZZ	137.07	0.15	4.18	15468
2025-11-12	JAZZ	136.71	0.17	0.68	15712
2025-11-13	JAZZ	141.8	0.17	0.11	15847
2025-11-14	JAZZ	141.09	0.17	0.08	16281
2025-11-17	JAZZ	170.14	0.16	0.51	16899
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-10-20	JAZZ	134.85	-10.3	1573.5	5.30
2025-10-21	JAZZ	137.53	-10.3	1598.7	5.30
2025-10-22	JAZZ	138.52	-10.6	1587.8	5.32
2025-10-23	JAZZ	138.30	-10.6	1579.9	5.32
2025-10-24	JAZZ	138.48	-10.6	1583.2	5.32
2025-10-27	JAZZ	139.33	-10.6	1586.4	5.32
2025-10-28	JAZZ	138.13	-11.7	1573.6	5.26
2025-10-29	JAZZ	135.68	-11.7	1565.6	5.26
2025-10-30	JAZZ	136.30	-11.5	1584.9	5.27
2025-10-31	JAZZ	137.64	-11.5	1589.9	5.27
2025-11-03	JAZZ	138.40	-11.5	1586.2	5.27
2025-11-04	JAZZ	137.87	-11.5	1578.0	5.27
2025-11-05	JAZZ	137.28	-11.5	1577.8	5.27
2025-11-06	JAZZ	134.02	-11.5	1560.7	5.27
2025-11-07	JAZZ	131.16	-11.5	1804.3	5.27
2025-11-10	JAZZ	133.19	-11.5	1796.6	5.27
2025-11-11	JAZZ	137.11	-7.0	1809.6	7.47
2025-11-12	JAZZ	136.69	-6.6	1780.2	7.52
2025-11-13	JAZZ	141.82	-6.6	1817.3	7.52
2025-11-14	JAZZ	141.07	-2.3	1779.1	8.17
2025-11-17	JAZZ	170.22	-2.3	1972.8	8.17
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-10-20	JAZZ	3.02	4.63	8.19
2025-10-21	JAZZ	3.02	4.63	8.19
2025-10-22	JAZZ	3.02	4.63	8.19
2025-10-23	JAZZ	3.02	4.63	8.19
2025-10-24	JAZZ	3.02	4.63	8.19
2025-10-27	JAZZ	3.02	4.21	8.12
2025-10-28	JAZZ	3.02	4.21	8.12
2025-10-29	JAZZ	3.02	4.21	8.12
2025-10-30	JAZZ	3.02	4.21	8.12
2025-10-31	JAZZ	3.02	4.21	8.12
2025-11-03	JAZZ	3.02	4.24	8.12
2025-11-04	JAZZ	3.02	4.24	8.12
2025-11-05	JAZZ	3.02	4.24	8.12
2025-11-06	JAZZ	3.08	4.24	8.12
2025-11-07	JAZZ	3.08	4.24	8.12
2025-11-10	JAZZ	3.07	3.72	8.11
2025-11-11	JAZZ	3.07	3.72	8.11
2025-11-12	JAZZ	3.07	3.72	8.85
2025-11-13	JAZZ	3.07	3.72	8.85
2025-11-14	JAZZ	-0.49	3.72	8.85
2025-11-17	JAZZ	-0.49	5.44	8.85
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

6.99

Avg. EPS Est. Current Quarter

6.45

Avg. EPS Est. Next Quarter

4.64

Insider Transactions

-0.49

Institutional Transactions

5.44

Beta

0.33

Average Sales Estimate Current Quarter

1158

Average Sales Estimate Next Quarter

987

Fair Value

140

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

9.9

Max Drawdown 5-Year %

-47.5

Target Price

194.25

P/E

Forward P/E

7.54

PEG

P/S

2.49

P/B

2.61

P/Free Cash Flow

7.73

EPS

-6.07

Average EPS Est. Cur. Y

8.17

EPS Next Y. (Est.)

22.69

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-8.86

Relative Volume

9.23

Return on Equity vs Sector %

-36.3

Return on Equity vs Industry %

-21.3

EPS 1 7Days Diff

2.9

EPS 1 30Days Diff

2.87

EBIT Estimation

1972.8

Jazz Pharmaceuticals plc

Sector: Healthcare

Industry: Biotechnology

Employees: 2800

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Xyrem for the treatment of cataplexy or EDS with narcolepsy; Epidiolex for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC); Rylaze for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma; Enrylaze to treat acute lymphoblastic leukemia and lymphoblastic lymphoma; Zepzelca for the treatment of metastatic small cell lung cancer with disease progression on or after platinum-based chemotherapy; Ziihera to treat HER2-positive biliary tract cancers; Defitelio to treat severe veno-occlusive disease; and Vyxeos for the treatment of newly-diagnosed therapy-related acute myeloid leukemia. It also develops Zanidatamab in Phase 3 trial to treat HER2-expressing gastroesophageal adenocarcinoma (GEA), and patients with HER2-expressing metastatic GEA; Epidiolex in Phase 3 trial to treat LGS, DS, and TSC; Suvecaltamide in Phase 2 trial to treat Parkinson's disease tremor; JZP815, a pan-RAF kinase inhibitor in Phase 1 trial that targets components of the mitogen-activated protein kinase; JZP898, a conditionally activated interferon alpha molecule in Phase 1 trial; JZP441 in Phase 1 trial to treat narcolepsy, IH, and other sleep disorders; JZP324, an extended-release low sodium oxybate formulation in Phase 1 trial for patients with sleep disorders; and JZP150 to treat post-traumatic stress disorder. The company has licensing and collaboration agreements with Redx Pharma plc, Autifony Therapeutics Limited, Zymeworks Inc., Sumitomo Pharma Co., Ltd., and Werewolf Therapeutics, Inc. Jazz Pharmaceuticals plc was founded in 2003 and is headquartered in Dublin, Ireland.

stock quote shares JAZZ – Jazz Pharmaceuticals plc Stock Price stock today

news today JAZZ – Jazz Pharmaceuticals plc stock forecast ,stock prediction 2023 2024 2025

marketwatch JAZZ – Jazz Pharmaceuticals plc yahoo finance google finance

stock history JAZZ – Jazz Pharmaceuticals plc invest stock market

stock prices JAZZ premarket after hours

ticker JAZZ fair value insiders trading

Jazz Pharmaceuticals plc

JAZZ

$170.09

Name : Jazz Pharmaceuticals plc

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $10,335,538,176.00

EPSttm : -6.15

Jazz Pharmaceuticals plc

$170.09

20.57%

$29.02

Float Short %

8.85

Margin Of Safety %

-18

Put/Call OI Ratio

0.16

EPS Next Q Diff

-2.35

EPS Last/This Y

-0.89

EPS This/Next Y

14.52

Price

170.22

Target Price

194.25

Analyst Recom

1.2

Performance Q

42.69

Relative Volume

9.23

Beta

0.33

Ticker: JAZZ

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-10-20	JAZZ	134.78	0.14	0.19	12533
2025-10-21	JAZZ	137.47	0.14	0.30	12626
2025-10-22	JAZZ	138.55	0.14	0.08	12724
2025-10-23	JAZZ	138.2	0.14	0.28	12981
2025-10-24	JAZZ	138.52	0.14	0.06	13006
2025-10-27	JAZZ	139.28	0.14	0.06	13075
2025-10-28	JAZZ	138.12	0.14	0.61	13324
2025-10-29	JAZZ	135.68	0.14	0.04	13353
2025-10-30	JAZZ	136.27	0.14	0.17	13355
2025-10-31	JAZZ	137.6	0.14	0.56	13367
2025-11-03	JAZZ	138.37	0.15	0.03	13527
2025-11-04	JAZZ	137.85	0.15	0.16	13530
2025-11-05	JAZZ	137.37	0.15	2.47	13556
2025-11-06	JAZZ	134.07	0.16	0.06	13736
2025-11-07	JAZZ	131.21	0.16	0.04	13947
2025-11-10	JAZZ	133.24	0.15	0.36	15369
2025-11-11	JAZZ	137.07	0.15	4.18	15468
2025-11-12	JAZZ	136.71	0.17	0.68	15712
2025-11-13	JAZZ	141.8	0.17	0.11	15847
2025-11-14	JAZZ	141.09	0.17	0.08	16281
2025-11-17	JAZZ	170.14	0.16	0.51	16899
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-10-20	JAZZ	134.85	-10.3	1573.5	5.30
2025-10-21	JAZZ	137.53	-10.3	1598.7	5.30
2025-10-22	JAZZ	138.52	-10.6	1587.8	5.32
2025-10-23	JAZZ	138.30	-10.6	1579.9	5.32
2025-10-24	JAZZ	138.48	-10.6	1583.2	5.32
2025-10-27	JAZZ	139.33	-10.6	1586.4	5.32
2025-10-28	JAZZ	138.13	-11.7	1573.6	5.26
2025-10-29	JAZZ	135.68	-11.7	1565.6	5.26
2025-10-30	JAZZ	136.30	-11.5	1584.9	5.27
2025-10-31	JAZZ	137.64	-11.5	1589.9	5.27
2025-11-03	JAZZ	138.40	-11.5	1586.2	5.27
2025-11-04	JAZZ	137.87	-11.5	1578.0	5.27
2025-11-05	JAZZ	137.28	-11.5	1577.8	5.27
2025-11-06	JAZZ	134.02	-11.5	1560.7	5.27
2025-11-07	JAZZ	131.16	-11.5	1804.3	5.27
2025-11-10	JAZZ	133.19	-11.5	1796.6	5.27
2025-11-11	JAZZ	137.11	-7.0	1809.6	7.47
2025-11-12	JAZZ	136.69	-6.6	1780.2	7.52
2025-11-13	JAZZ	141.82	-6.6	1817.3	7.52
2025-11-14	JAZZ	141.07	-2.3	1779.1	8.17
2025-11-17	JAZZ	170.22	-2.3	1972.8	8.17
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-10-20	JAZZ	3.02	4.63	8.19
2025-10-21	JAZZ	3.02	4.63	8.19
2025-10-22	JAZZ	3.02	4.63	8.19
2025-10-23	JAZZ	3.02	4.63	8.19
2025-10-24	JAZZ	3.02	4.63	8.19
2025-10-27	JAZZ	3.02	4.21	8.12
2025-10-28	JAZZ	3.02	4.21	8.12
2025-10-29	JAZZ	3.02	4.21	8.12
2025-10-30	JAZZ	3.02	4.21	8.12
2025-10-31	JAZZ	3.02	4.21	8.12
2025-11-03	JAZZ	3.02	4.24	8.12
2025-11-04	JAZZ	3.02	4.24	8.12
2025-11-05	JAZZ	3.02	4.24	8.12
2025-11-06	JAZZ	3.08	4.24	8.12
2025-11-07	JAZZ	3.08	4.24	8.12
2025-11-10	JAZZ	3.07	3.72	8.11
2025-11-11	JAZZ	3.07	3.72	8.11
2025-11-12	JAZZ	3.07	3.72	8.85
2025-11-13	JAZZ	3.07	3.72	8.85
2025-11-14	JAZZ	-0.49	3.72	8.85
2025-11-17	JAZZ	-0.49	5.44	8.85
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

6.99

Avg. EPS Est. Current Quarter

6.45

Avg. EPS Est. Next Quarter

4.64

Insider Transactions

-0.49

Institutional Transactions

5.44

Beta

0.33

Average Sales Estimate Current Quarter

1158

Average Sales Estimate Next Quarter

987

Fair Value

140

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

9.9

Max Drawdown 5-Year %

-47.5

Target Price

194.25

P/E

Forward P/E

7.54

PEG

P/S

2.49

P/B

2.61

P/Free Cash Flow

7.73

EPS

-6.07

Average EPS Est. Cur. Y

8.17

EPS Next Y. (Est.)

22.69

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-8.86

Relative Volume

9.23

Return on Equity vs Sector %

-36.3

Return on Equity vs Industry %

-21.3

EPS 1 7Days Diff

2.9

EPS 1 30Days Diff

2.87

EBIT Estimation

1972.8

Jazz Pharmaceuticals plc

Sector: Healthcare

Industry: Biotechnology

Employees: 2800

stock quote shares JAZZ – Jazz Pharmaceuticals plc Stock Price stock today

news today JAZZ – Jazz Pharmaceuticals plc stock forecast ,stock prediction 2023 2024 2025

marketwatch JAZZ – Jazz Pharmaceuticals plc yahoo finance google finance

stock history JAZZ – Jazz Pharmaceuticals plc invest stock market

stock prices JAZZ premarket after hours

ticker JAZZ fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: JAZZ

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: JAZZ

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y